Tokio Marine HCC
HCC
$87.35
+2.51%
Warrior Met Coal, Inc. (NYSE: HCC) is a pure-play producer and exporter of premium metallurgical (met) coal, mined from its underground longwall operations — Mine No. 4, Mine No. 7, and the developing Blue Creek project — in Alabama, with the coal sold to steelmakers across Asia, Europe, and South America; the company also captures and sells natural gas extracted from its coal seams. As one of the few large-scale, publicly traded U.S. suppliers of seaborne hard-coking coal, Warrior occupies a distinct niche in the global steelmaking supply chain rather than competing in thermal-power coal, giving it direct leverage to global steel utilization and premium coking-coal benchmarks. The current investor narrative is dominated by the Blue Creek growth ramp — a multi-year, capital-intensive project intended to lift output and lower unit costs — set against a volatile met-coal price environment that has produced sharply uneven quarterly earnings, including a loss in Q1 2025 followed by a strong Q4 2025 rebound. With a small share count, a low dividend yield, and a stock that has swung from roughly $60 to $111 over the past year, the debate centers on whether Blue Creek volumes can drive durable earnings power before coal-price softness or steel-demand weakness erodes the margin recovery.…
HCC
Tokio Marine HCC
$87.35
Investment Opinion: Should I buy HCC Today?
Based on the synthesis of data, the recommendation is a Hold with a bullish bias. The core thesis is that Warrior Met Coal offers significant upside potential from the Blue Creek growth project, but the risks of negative free cash flow, earnings volatility, and a premium valuation warrant caution until tangible progress is demonstrated. The analyst consensus average target price of $105.17 implies 19.6% upside, and recent Buy ratings from UBS, Citigroup, and others suggest institutional confidence, but the wide target range of $90 to $125 reflects uncertainty.
Supporting evidence includes the 29.09% year-over-year revenue growth in Q4 2025 to $383.99 million, a strong balance sheet with debt-to-equity of 0.127 and current ratio of 3.19, and a forward PE of 12.87x that is attractive if earnings recover as expected. However, the trailing PE of 81.64x and EV/EBITDA of 18.09x are elevated, and free cash flow is negative at -$111.21 million TTM. The company's net margin of 4.35% is thin, and ROE of 2.66% is weak. The stock's beta of 0.688 suggests lower volatility, but the 29.51% max drawdown highlights risk.
The biggest risks that could invalidate the thesis are: (1) a failure to achieve Blue Creek volume targets, leading to continued negative FCF and potential liquidity issues; (2) a decline in met-coal prices due to weak global steel demand, compressing margins; and (3) multiple compression if growth disappoints, given the rich EV/EBITDA. The rating would upgrade to Buy if free cash flow turns positive and Blue Creek volumes ramp as planned, or if the stock pulls back to a more attractive valuation (e.g., forward PE below 10x). It would downgrade to Sell if revenue growth decelerates below 10% or if FCF remains negative for multiple quarters. Relative to its history and peers, HCC appears overvalued on trailing metrics but fairly valued on forward earnings, assuming the recovery materializes. The valuation verdict is that the stock is pricing in a successful Blue Creek ramp, leaving little room for error.
Sign up to view all
HCC 12-Month Price Forecast
The 12-month outlook for HCC is balanced, with a slight tilt towards the base case given the binary nature of the Blue Creek ramp. The bull case (30% probability) hinges on successful project execution and firm coal prices, while the bear case (20%) reflects risks of delays and price declines. The base case (50%) assumes steady progress and stable prices, leading to a target range of $95-$110. Key factors include the company's ability to generate positive free cash flow, which is critical for valuation support. The analyst consensus is bullish, but the wide EPS dispersion ($3.81-$14.12) underscores uncertainty. I would upgrade to bullish if FCF turns positive and Blue Creek volumes meet targets; I would downgrade to bearish if met-coal prices fall below $150/tonne or if FCF remains negative for multiple quarters.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Tokio Marine HCC's 12-month outlook, with a consensus price target around $109.00 and implied upside of +24.8% versus the current price.
Average Target
$109.00
0 analysts
Implied Upside
+24.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$100 - $122
Analyst target range
Six analysts cover Warrior Met Coal, and the sentiment is constructive: the consensus average target price is $105.17, implying roughly 19.6% upside from the current $87.93, with a target range of $90.00 to $125.00. The recommendation field is listed as "none," but the institutional ratings history shows a clear bullish tilt — UBS upgraded the stock from Neutral to Buy on January 29, 2026, and has reiterated Buy three times since (March 12 and March 27, 2026), while Citigroup, B. Riley Securities, and Jefferies have all maintained Buy ratings in 2026. The consensus therefore leans bullish, with the average target sitting above the current price and even the lowest target ($90.00) modestly above the market price.
The target range is relatively wide — $90.00 to $125.00, a 39% spread from low to high — signaling meaningful uncertainty about the Blue Creek ramp and met-coal pricing. The high target of $125.00 implies roughly 42% upside and likely assumes successful Blue Creek volume delivery, firm seaborne coking-coal prices, and multiple expansion on normalized earnings; the low target of $90.00 implies only about 2.4% upside and prices in flat-to-soft coal prices with slower volume growth or margin compression. The consensus EPS estimate of $9.30 (range $3.81 to $14.12) is remarkably wide, reinforcing that the earnings outlook is highly binary, while estimated average revenue of $2.32 billion (range $2.00–$2.56 billion) implies analysts expect a substantial top-line step-up from the trailing run-rate. The recent pattern of upgrades and reiterated Buy ratings suggests analysts are positioning for the Blue Creek growth story, but the wide dispersion in both targets and EPS estimates means investors should treat the consensus as directionally bullish rather than precisely calibrated.
Drowning in data?
Find the real signal!
Bulls vs Bears: HCC Investment Factors
The bull case for Warrior Met Coal rests on the successful ramp of the Blue Creek project, which is expected to drive substantial revenue and earnings growth, supported by a strong balance sheet and bullish analyst sentiment. However, the bear case highlights significant risks: negative free cash flow, extreme earnings volatility, a rich EV/EBITDA multiple, and weak near-term momentum. Currently, the bear evidence appears stronger due to the company's cash burn and the stock's recent underperformance, but the bull case could prevail if Blue Creek delivers. The single most important tension is whether Blue Creek can generate sufficient volume and cost improvements to justify the premium valuation before met-coal prices or steel demand weaken. This binary outcome makes HCC a high-risk, high-reward proposition.
Bullish
- Blue Creek Ramp Drives Volume Growth: The Blue Creek project is expected to significantly increase production and lower unit costs, as evidenced by the 29.09% year-over-year revenue growth in Q4 2025 to $383.99 million. Analysts forecast revenue to reach $2.32 billion on average, implying a substantial step-up from the trailing run-rate, which supports the growth narrative.
- Strong Balance Sheet with Low Leverage: Debt-to-equity is only 0.127 and the current ratio is 3.19, indicating a conservative capital structure. With $307.85 million in cash, the company has ample liquidity to fund the Blue Creek buildout without financial distress.
- Analyst Consensus Leans Bullish: The average analyst target price is $105.17, implying 19.6% upside from the current $87.93. Recent upgrades and reiterated Buy ratings from UBS, Citigroup, B. Riley, and Jefferies signal growing confidence in the growth story.
- Attractive Forward Valuation: The forward PE of 12.87x is reasonable if earnings recover as expected, with consensus EPS of $9.30. This compares favorably to the trailing PE of 81.64x, which is distorted by depressed earnings, and suggests significant earnings growth is priced in.
Bearish
- Negative Free Cash Flow and High Capex: Trailing twelve-month free cash flow is -$111.21 million, with Q4 2025 FCF of -$18.12 million and Q1 2025 FCF of -$68.43 million, driven by heavy capital expenditures of $94.21 million in Q4 alone. The company is burning cash to fund Blue Creek, and FCF must reverse to justify the valuation.
- Extreme Earnings Volatility: Net income swung from a $8.17 million loss in Q1 2025 to $22.96 million in Q4 2025, and net margin collapsed from 27.21% in Q1 2024 to -2.72% in Q1 2025. This extreme sensitivity to met-coal prices leaves little margin for error.
- Rich EV/EBITDA Multiple: The EV/EBITDA of 18.09x is well above the 4-8x range typical for coal miners in mid-cycle, suggesting the market is already capitalizing much of the Blue Creek growth before it is delivered. If growth disappoints, multiple compression could be severe.
- Weak Near-Term Momentum: The stock is down 16.30% over the past month and 2.93% over three months, significantly lagging the S&P 500. This negative momentum, combined with a 29.51% maximum drawdown, indicates high risk of further declines.
HCC Technical Analysis
Warrior Met Coal is in a choppy, range-bound recovery rather than a clean trend: the shares are up 37.82% over the past year but down 1.81% year-to-date, and at $87.93 the stock sits at roughly 53% of its 52-week range (52-week low of $60.70, high of $111.42). That mid-range positioning signals neither momentum-driven overextension nor deep-value capitulation — the market has repeatedly repriced the name between the low $60s and low $110s as met-coal prices and Blue Creek news flow have shifted. The 29.51% maximum drawdown over the period underscores how violently the stock can retrace even within a positive 1-year return.
Short-term momentum has deteriorated sharply and now diverges from the longer-term uptrend: HCC is down 16.30% over the past month and 2.93% over three months, versus a 37.82% one-year gain, and the stock has fallen from $108.53 on September 2 to $87.93 on September 18 — a roughly 19% slide in under three weeks. Relative strength confirms the decoupling, with HCC lagging SPY by 15.34 percentage points over one month and 4.93 points over three months, even though it leads by 22.81 points over a full year. This pattern — strong 12-month performance but sharply negative near-term momentum — typically signals profit-taking and mean reversion within an intact longer-term range rather than a confirmed trend reversal, though the velocity of the decline warrants caution.
Key technical levels are well defined: support sits at the 52-week low of $60.70, with an intermediate zone around the July lows near $77–$80, while resistance is the 52-week high of $111.42, with the recent $108 area acting as a nearer ceiling. A breakout above $111.42 would confirm a new leg higher and likely require a met-coal price catalyst or positive Blue Creek update, whereas a breakdown below $80 would threaten the 1-year uptrend and put the $60.70 low in play. With a beta of just 0.688, HCC is roughly 31% less volatile than the broader market on a statistical basis, which argues for smaller position-sizing adjustments than a high-beta cyclical would demand — though the 6.52 short ratio and 1.997 million share volume indicate meaningful speculative interest that can amplify moves around catalysts.
Beta
0.74
0.74x market volatility
Max Drawdown
-29.5%
Largest decline past year
52-Week Range
$62-$111
Price range past year
Annual Return
+35.6%
Cumulative gain past year
| Period | HCC Return | S&P 500 |
|---|---|---|
| 1m | -2.4% | -0.2% |
| 3m | +10.5% | +5.5% |
| 6m | -2.8% | +7.1% |
| 1y | +35.6% | +12.3% |
| ytd | -2.5% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HCC Fundamental Analysis
Warrior's revenue trajectory has been volatile but is re-accelerating off a trough: Q4 2025 revenue of $383.99 million grew 29.09% year-over-year versus $297.47 million in Q4 2024, and rose sequentially from $327.88 million in Q3 2025 and $297.52 million in Q2 2025. The quarterly arc through 2025 — $299.94 million (Q1), $297.52 million (Q2), $327.88 million (Q3), $383.99 million (Q4) — shows a clear sequential recovery after a weak first half, with the product segment contributing $373.63 million of Q4 revenue versus just $10.36 million from other products and services. The growth trend implies the investment case is increasingly levered to volume recovery and Blue Creek ramp rather than price alone, though the 2024 comparison base was itself depressed by weak met-coal pricing.
Profitability is thin and highly cyclical despite a headline gross margin of 98.95% in Q4 2025 (a figure distorted by the company's classification of nearly all costs below the gross-profit line, with cost of revenue of only $4.04 million against $345.30 million of operating expenses). Net income was $22.96 million in Q4 2025, a 5.98% net margin, recovering from a $8.17 million loss in Q1 2025 and building on $36.60 million in Q3 2025 and $5.61 million in Q2 2025; the company's operating margin of 3.48% and net margin of 4.35% on a trailing basis are far below the 20%+ margins HCC earned in 2022–2023, when gross margins reached 33.4% (Q1 2024) and net margins exceeded 27%. The swing from a 27.21% net margin in Q1 2024 to a negative 2.72% in Q1 2025 illustrates extreme earnings sensitivity to realized met-coal prices, and the current mid-single-digit margins leave little cushion if pricing softens again.
Balance-sheet health is a genuine strength: debt-to-equity is only 0.127, the current ratio is 3.19, and cash of $307.85 million at year-end 2025 covers short-term obligations comfortably, while interest coverage of 14.21x on trailing EBIT is solid. However, free cash flow is negative — trailing twelve-month FCF of -$111.21 million, with Q4 2025 FCF of -$18.12 million and Q1 2025 FCF of -$68.43 million — driven by heavy capital expenditure of $94.21 million in Q4 alone and $79.35 million in Q1, reflecting the Blue Creek buildout. ROE of just 2.66% and ROA of 5.17% are weak relative to the company's historical 6–23% ROE range, and the cash flow statement shows the company is funding growth from its balance sheet rather than internal cash generation, a dynamic that must reverse as Blue Creek comes online to justify the current valuation.
Quarterly Revenue
$509690000.0B
2026-06
Revenue YoY Growth
+70.6%
YoY Comparison
Gross Margin
20.5%
Latest Quarter
Free Cash Flow
$6134001.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HCC Overvalued?
Because Warrior Met Coal is profitable on a trailing basis — trailing net income is positive, with EPS of $0.0123 and Q4 2025 net income of $22.96 million — the PE ratio is the appropriate primary metric, though its usefulness is limited by the depressed earnings base. The trailing PE of 81.64x is extraordinarily elevated, but the forward PE of 12.87x tells a dramatically different story: the market expects earnings to roughly sextuple, consistent with consensus estimated EPS of $9.30 versus the trailing $0.0123. That enormous trailing-to-forward gap implies the market is pricing in a full Blue Creek volume ramp and a recovery in met-coal realizations, making the stock highly sensitive to any disappointment in that trajectory.
Relative to the broader Energy sector and coal peers, HCC's multiples are mixed: the price-to-sales ratio of 3.54x and price-to-book of 2.16x are moderate for a commodity producer, but EV/EBITDA of 18.09x is rich versus the 4–8x range typical for coal miners in mid-cycle, and the PEG ratio of -1.05 is meaningless given the negative earnings base. The forward PE of 12.87x is the more relevant comparison and sits at a modest premium to where diversified miners trade in normalized markets, arguably justified by HCC's premium hard-coking coal product mix, low debt, and Blue Creek growth optionality — but the 18.09x EV/EBITDA multiple suggests the market is already capitalizing much of that growth before it is delivered.
Historically, HCC has traded at far lower multiples: its PE ranged from 2.39x (Q4 2021) to 7.78x (Q3 2023) during the 2021–2023 coal upcycle, and its PS ratio ranged from 3.18x to 12.08x over the past several years, with the current 3.54x PS near the lower end of that band. The current trailing PE of 81.64x is near the top of its historical range, but this reflects earnings depression rather than multiple expansion — the stock's 2.16x P/B is above the 1.09–1.87x range seen through 2022–2024, suggesting the market is paying up for the balance sheet and growth pipeline. The key takeaway is that valuation is entirely a function of the forward earnings recovery: if consensus EPS of $9.30 materializes, the stock trades at a reasonable 12.87x forward earnings, but if met-coal prices or Blue Creek volumes disappoint, the multiple would look expensive against a much weaker earnings base.
PE
81.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 1x~23x
vs. Industry Avg
16.1x
Industry PE ~16.1x*
EV/EBITDA
18.2x
Enterprise Value Multiple
Investment Risk Disclosure
Warrior Met Coal faces significant financial and operational risks. The company generated negative free cash flow of -$111.21 million over the trailing twelve months, with Q4 2025 FCF of -$18.12 million and Q1 2025 FCF of -$68.43 million, driven by heavy capital expenditures of $94.21 million in Q4 alone for the Blue Creek project. This cash burn is funded from the balance sheet, and while debt-to-equity is low at 0.127 and cash stands at $307.85 million, continued negative FCF could erode liquidity if the project encounters delays or cost overruns. Additionally, earnings are highly volatile, with net income swinging from a $8.17 million loss in Q1 2025 to $22.96 million in Q4 2025, and net margin collapsing from 27.21% in Q1 2024 to -2.72% in Q1 2025, reflecting extreme sensitivity to met-coal prices. The company's profitability is thin, with a trailing net margin of 4.35% and operating margin of 3.48%, leaving little cushion if prices decline.
Market and competitive risks are also prominent. HCC trades at a rich EV/EBITDA of 18.09x, well above the 4-8x range typical for coal miners, suggesting that much of the Blue Creek growth is already priced in. If the project disappoints or met-coal prices weaken, multiple compression could be severe. The stock has a beta of 0.688, indicating lower volatility than the market, but it still exhibits a 29.51% maximum drawdown over the past year, and its 52-week range of $60.70 to $111.42 shows significant price swings. Competitive pressures from other met-coal producers, such as those in Australia, could impact pricing and market share. Additionally, the company's revenue is concentrated in Asia, Europe, and South America, exposing it to geopolitical and trade risks, as well as global steel demand fluctuations.
The worst-case scenario would involve a combination of falling met-coal prices, delays or cost overruns at Blue Creek, and a deterioration in global steel demand. This could lead to sustained negative free cash flow, eroding the balance sheet and forcing the company to cut capital expenditures or dividends. In such a scenario, the stock could retest its 52-week low of $60.70, representing a decline of approximately 31% from the current price of $87.93. The analyst low target of $90.00 offers minimal downside protection, but if earnings fail to materialize, the stock could fall further. A more severe downturn, similar to the 2020 coal slump, could see the stock drop below $60, implying a loss of over 30% from current levels. Investors should be prepared for significant volatility and potential capital impairment.
FAQ
The key risks include: 1) Financial risk: negative free cash flow of -$111.21 million TTM and high capex could strain liquidity if Blue Creek delays occur. 2) Earnings volatility: net income swung from a $8.17 million loss in Q1 2025 to $22.96 million in Q4 2025, and margins are thin at 4.35% net. 3) Valuation risk: EV/EBITDA of 18.09x leaves room for multiple compression if growth disappoints. 4) Market risk: beta of 0.688 is low, but the stock has a 29.51% max drawdown and is sensitive to met-coal prices and global steel demand. These risks are ranked from high to moderate, with financial and earnings risks being the most immediate.
The 12-month forecast has three scenarios: bull case (30% probability) targets $111.42-$125.00, assuming successful Blue Creek ramp and firm coal prices; base case (50%) targets $95-$110, assuming steady progress and stable prices; bear case (20%) targets $60.70-$90.00, assuming delays and price declines. The base case is most likely, with a target around the analyst average of $105.17. The key assumption is that Blue Creek reaches 80% capacity by year-end 2026 and met-coal prices remain within 10% of current levels. However, the wide analyst EPS range of $3.81 to $14.12 means outcomes could vary significantly.
HCC's valuation is a tale of two metrics: the trailing PE of 81.64x is extremely high, but the forward PE of 12.87x is reasonable if earnings materialize. The EV/EBITDA of 18.09x is rich compared to the 4-8x typical for coal miners, suggesting the market is pricing in significant growth. The price-to-book of 2.16x is above its historical range of 1.09-1.87x, indicating a premium. Relative to peers, HCC appears overvalued on current earnings but fairly valued on forward estimates. The market is expecting a successful Blue Creek ramp and a recovery in met-coal prices; if these fail to materialize, the stock could be significantly overvalued.
HCC presents a high-risk, high-reward opportunity. The analyst average target of $105.17 implies 19.6% upside, and the forward PE of 12.87x is attractive if earnings recover as expected. However, the company is burning cash with negative FCF of -$111.21 million TTM, and the stock has fallen 16.30% in the past month. It could be a good buy for investors who believe in the Blue Creek growth story and can tolerate volatility, but the wide EPS estimate range of $3.81 to $14.12 highlights the uncertainty. A more prudent approach might be to wait for positive free cash flow or a pullback to the $80 support level before initiating a position.
HCC is more suitable for long-term investment, given its growth stage and the multi-year Blue Creek project. The stock's beta of 0.688 suggests lower volatility, but it has a 29.51% max drawdown and negative near-term momentum, making it risky for short-term trading. The dividend yield is low at 0.38%, so income is not a primary return driver. Earnings visibility is low due to coal price volatility, but the Blue Creek ramp could drive substantial growth over 2-3 years. A minimum holding period of 2-3 years is recommended to allow the project to mature and cash flow to turn positive. Short-term traders might capitalize on volatility around earnings, but the risk is high.